Priming and Filling the Pump

Key steps to help minimize loss of PRIALT at first fill and ensure administration of appropriate dose.6

How to Prime and Fill a Naïve Pump

Step 1: Prime

  • The first time that the pump is used with PRIALT, it must be primed
  • Using a 5-mL syringe, remove 2 mL from the vial of undiluted 25 mcg/mL PRIALT
  • Use only the undiluted PRIALT for naïve pump priming. Set aside the remaining 18 mL in the vial

Step 2: Rinse

  • Attach the syringe to the catheter with a luer lock connector and rinse the internal surfaces of the pump with the 2 mL of undiluted PRIALT
  • Discard the used 2-mL solution after the rinse
  • Repeat this rinse procedure 2 more times─for a total of 3 rinses
  • A naïve pump must be rinsed 3 times in order to prevent a reduction in the dose during the initial fill

Step 3: Fill

  • Using a 20-mL syringe, remove the remaining 14 mL of undiluted PRIALT from the vial
  • Fill the pump with the 14 mL of PRIALT and set the appropriate dose and flow rate. Initiate dosing with PRIALT at a delivery rate no higher than 2.4 mcg per day or 0.1 mcg per hour

On or Before Day 14: Refill

  • Discard the remaining PRIALT in the pump and perform the first pump refill
  • The IT pump should be refilled using a new vial of PRIALT within 14 days of the initial pump fill to help ensure appropriate dose administration
Importance of Titration
Pump Concentration
Priming and Filling the Pump
pg19HCP_videoFPO
WATCH
A VIDEO
on how to set up and
start on PRIALT
PRIALT bottle

Important Safety Information

  • PRIALT should be administered intrathecally (IT) by or under the direction of a physician. PRIALT is not intended for intravenous (IV) administration. See full Prescribing Information for dosing and administration instructions.
  • The combination of PRIALT with intrathecal opiates has not been studied in placebo-controlled clinical trials and is not recommended.
  • PRIALT is for use only in the Medtronic SynchroMed® II Infusion System and the CADD-Micro Ambulatory Infusion Pump.
  • Advise patients to contact a physician if they experience new or worsening muscle pain, soreness, or weakness with or without darkened urine.

Please see full Prescribing Information, including BOXED Warning, and click here for additional Important Safety Information.

Reference: 6. PRIALT [package insert]. Palo Alto, CA: Jazz Pharmaceuticals; February 2013.